Amneal Pharmaceuticals (AMRX) Depreciation and Depletion (2017 - 2018)

Amneal Pharmaceuticals (AMRX) recorded quarterly Depreciation and Depletion of $18.6 million in Q4 2018, up 7.25% quarter-over-quarter from $17.4 million in Q3 2018, and up 56.19% on a YoY basis from $11.9 million in Q4 2017.

Amneal Pharmaceuticals (AMRX) Depreciation and Depletion (2017 - 2018) Analysis & Trends

Amneal Pharmaceuticals' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $18.6 million for Q4 2018.

  • In Q4 2018, Depreciation and Depletion rose 56.19% year-over-year to $18.6 million; the TTM figure through Dec 2018 stood at $63.3 million (changed N/A YoY), while the FY2025 annual figure was $57.3 million, down 8.47% from the prior year.
  • Depreciation and Depletion was $18.6 million for Q4 2018 at Amneal Pharmaceuticals, up from $17.4 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $18.6 million in Q4 2018 to a low of $9.6 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 36.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 21.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 28.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Amneal Pharmaceuticals 4.66 Bn 4.65 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 18.62 Mn
Dec 31, 2018 18.62 Mn
Sep 30, 2018 17.36 Mn
Sep 30, 2018 17.36 Mn
Jun 30, 2018 15.45 Mn
Jun 30, 2018 15.45 Mn
Dec 31, 2017 11.92 Mn
Dec 31, 2017 11.92 Mn
Sep 30, 2017 10.68 Mn
Sep 30, 2017 10.68 Mn
Jun 30, 2017 9.65 Mn
Jun 30, 2017 9.65 Mn